Oaktree Specialty Lending (OCSL) CEO adds 1,700 shares in open-market buy

Rhea-AI Filing Summary

Oaktree Specialty Lending Corp reports that Chief Executive Officer and Co-Chief Investment Officer Armen Panossian purchased 1,700 shares of its common stock on 2026-08-12 in an open-market or private transaction at $12.6945 per share. Following this transaction, his directly held position is 22,489 shares of common stock.

Insider Trade Summary

Net Buyer: 1,700 shares

Net Buy 1 txn

Insider Panossian Armen

Role See Remarks

Bought 1,700 shs ($22K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.01 per share	1,700	$12.6945	$22K

Holdings After Transaction: Common Stock, par value $0.01 per share — 22,489 shares (Direct)

Key Figures

Shares purchased: 1,700 shares Purchase price: $12.6945 per share Holdings after transaction: 22,489 shares

3 metrics

Shares purchased 1,700 shares Non-derivative open-market or private purchase on 2026-08-12

Purchase price $12.6945 per share Price paid for OCSL common stock on 2026-08-12

Holdings after transaction 22,489 shares Directly owned OCSL common stock following the reported purchase

Key Terms

non-derivative, open-market or private transaction, Common Stock, par value $0.01 per share

3 terms

non-derivative financial

"classified as a <b>non-derivative</b> open-market or private transaction"

open-market or private transaction financial

"Purchase in <b>open market or private transaction</b>"

Common Stock, par value $0.01 per share financial

"bought <b>Common Stock, par value $0.01 per share</b> of Oaktree"

FAQ

What insider transaction did OCSL report for Armen Panossian?

Armen Panossian purchased 1,700 shares of Oaktree Specialty Lending Corp common stock on 2026-08-12 in a non-derivative open-market or private transaction at $12.6945 per share.

How many OCSL shares does Armen Panossian own after this purchase?

After the reported transaction, Armen Panossian directly owns 22,489 shares of Oaktree Specialty Lending Corp common stock, reflecting the addition of 1,700 shares acquired on 2026-08-12.

At what price were the newly acquired OCSL shares bought?

The 1,700 Oaktree Specialty Lending Corp shares were purchased at a price of $12.6945 per share, classified as a non-derivative transaction in common stock, par value $0.01 per share.

Was the OCSL insider trade made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating use of a trading plan, so the purchase is not reported as made under a Rule 10b5-1 plan.

What type of security did Armen Panossian buy in OCSL?

Armen Panossian bought Common Stock, par value $0.01 per share of Oaktree Specialty Lending Corp, recorded as a non-derivative transaction in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 04:05 PM Accepted by SEC EDGAR 08/13/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Panossian Armen

(Last) (First) (Middle)

C/O OAKTREE SPECIALTY LENDING CORP

333 SOUTH GRAND AVENUE, 28TH FLOOR

(Street)

LOS ANGELES CALIFORNIA 90071

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oaktree Specialty Lending Corp [ OCSL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	08/12/2026		P		1,700	A	$12.6945	22,489	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Chief Executive Officer and Co-Chief Investment Officer

	/s/ Mary Gallegly, attorney-in-fact	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)